MAC is exhibiting at the American Headache Society’s 60th Annual Scientific Meeting in San Francisco 28 June – 1 July 2018
MAC’s GMP pharmacy manufacturing department currently supports our MHRA accredited Phase 1 research centre in Manchester and late phase dedicated
Defying Dementia is raising funds for Dementia research.
MAC is very proud to announce that Dr Mark Dale (CEO) has been awarded Honorary Membership of the Faculty of
MAC Neuroscience Centre of excellence, the early phase division of MAC Clinical Research, has been awarded Accreditation from the Medicines and Healthcare products Regulatory Agency (MHRA).
MAC will be exhibiting at this year’s PCT conference in Vienna 16 – 17 November 2016.
MAC will be exhibiting at this year’s Exploratory Clinical Development World Congress in Berlin 26th – 27th October 2016.
MAC meets the Alzheimer’s disease research team with Dr Penny Foulds at Lancaster University.
MAC’s Chief Research and Development Officer, Dr John Connell will be speaking at the 35th Annual Scientific Meeting of the
Follow MAC Clinical Research on social media to keep up to date with our latest news and updates.
